Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
Clinical trial NCT07333066 · RECRUITING
Trial details
- NCT number
- NCT07333066
- Sponsor
- Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2030-03-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.